1ABBV:BIT
AbbVie Common Stock
€232.10
arrow_downward
-0.34%(-0.80) 1D
Oct 1, 5:26:00 PM GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 1ABBV...
Open
€234.50
High
€234.50
Low
€232.10
Mkt. cap
458.48B
Avg. vol.
34.00
Volume
38.00
52-wk high
€234.90
52-wk low
€168.00
No. of employees
57K
Open
€234.50
High
€234.50
Low
€232.10
Mkt. cap
458.48B
Avg. vol.
34.00
Volume
38.00
52-wk high
€234.90
52-wk low
€168.00
No. of employees
57K
News stories
From web sources and news partners
Kalkine Media
·
1 hour ago
Why Is AbbVie (NYSE:ABBV) Suddenly a Must-Watch Healthcare Stocks Stock Today?
Investing.com Canada
·
1 hour ago
AbbVie reports long-term vitiligo data for RINVOQ at EADV By Investing.com
Investing News Network
·
2 hours ago
AbbVie to Host Third-Quarter 2026 Earnings Conference Call
The Globe and Mail
·
2 hours ago
ABBV Stock Rises 25% in 6 Months: Time to Buy, Hold or Sell?
Profile
AbbVie Inc., also known as AbbVie, is an American pharmaceutical company headquartered in North Chicago, Illinois. AbbVie produces drugs to treat a wide range of medical issues.
The company is ranked sixth on the list of largest biomedical companies by revenue. It is ranked 77th on the Fortune 500 and 108th on the Forbes Global 2000. The name "AbbVie" is derived from a combination of "Abbott", the name of its former parent company, with "vie", intended as a reference to a Latin root meaning 'life'. Wikipedia
About AbbVie Common Stock
CEORobert A. Michael
Employees57K
FoundedApr 10, 2012
HeadquartersNorth Chicago, Illinois, United States
SectorBiotechnology
Websiteabbvie.com